| VANCOUVER, British Columbia, December 5, 2019 – MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”) is pleased to announce it has paid back the Trichome loan in full, is now completely debt-free, and maintains a healthy cash-positive bank balance. Although the Trichome loan has been fully paid and there are no further obligations from MYM to Trichome with respect to the loan, Trichome remains supportive of the Company exploring potential acquisitions in the future. As such, the Company will continue its exploration to find great value, given current market conditions, and looks forward to working with Trichome on future projects. “We are committed to our strategy of focused opportunistic acquisition. We remain debt-free with the ability to potentially access additional capital should the right opportunity present itself,” said Howard Steinberg, CEO of MYM. “With the increasingly complex capital market environment in the cannabis industry, we believe there are companies with valuable core assets that are poised to benefit from the restructuring expertise our team can bring, in terms of both capital and management support.” “While we are pleased to have been repaid on our loan, we remain supportive of MYM as they pursue strategic options that may arise,” said Michael Ruscetta, Trichome Financials’ Chief Executive Officer. In addition to the above, the BioHemp rescission is now complete. The transaction, by court order, has been rescinded and therefore treated as if it never occurred. |